123 related articles for article (PubMed ID: 29208488)
1. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
2. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of protein capture from a human cancer cell line by genomic G-quadruplex DNA sequences toward aptamer discovery.
Morrissey KL; DeWitt D; Shah N; Fall W; Shah H; McGown LB
Anal Bioanal Chem; 2021 Jun; 413(14):3775-3788. PubMed ID: 33884462
[TBL] [Abstract][Full Text] [Related]
5. Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs.
Riccardi C; Musumeci D; Platella C; Gaglione R; Arciello A; Montesarchio D
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183039
[TBL] [Abstract][Full Text] [Related]
6. Structural and Biological Features of G-Quadruplex Aptamers as Promising Inhibitors of the STAT3 Signaling Pathway.
Esposito V; Benigno D; Bello I; Panza E; Bucci M; Virgilio A; Galeone A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298475
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Jo J; Bae S; Jeon J; Youn H; Lee G; Ban C
Bioconjug Chem; 2023 Jan; 34(1):238-247. PubMed ID: 36516871
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
Zhang WY; Chen HL; Chen QC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV Activities of Intramolecular G4 and Non-G4 Oligonucleotides.
Prokofjeva M; Tsvetkov V; Basmanov D; Varizhuk A; Lagarkova M; Smirnov I; Prusakov K; Klinov D; Prassolov V; Pozmogova G; Mikhailov SN
Nucleic Acid Ther; 2017 Feb; 27(1):56-66. PubMed ID: 27763826
[TBL] [Abstract][Full Text] [Related]
10. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
11. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
12. G4 Aptamers: Trends in Structural Design.
Varizhuk A; Ilyinsky N; Smirnov I; Pozmogova G
Mini Rev Med Chem; 2016; 16(16):1321-1329. PubMed ID: 26996618
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
Marques LA; Semprebon SC; Niwa AM; D'Epiro GF; Sartori D; de Fátima Â; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1279-1288. PubMed ID: 27592117
[TBL] [Abstract][Full Text] [Related]
14. Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity.
Napolitano E; Criscuolo A; Riccardi C; Esposito CL; Catuogno S; Coppola G; Roviello GN; Montesarchio D; Musumeci D
Angew Chem Int Ed Engl; 2024 Apr; 63(16):e202319828. PubMed ID: 38358301
[TBL] [Abstract][Full Text] [Related]
15. Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma.
Hu J; Zhao Z; Liu Q; Ye M; Hu B; Wang J; Tan W
Chem Asian J; 2015 Jul; 10(7):1519-25. PubMed ID: 25864879
[TBL] [Abstract][Full Text] [Related]
16. uL3 Mediated Nucleolar Stress Pathway as a New Mechanism of Action of Antiproliferative G-quadruplex TBA Derivatives in Colon Cancer Cells.
Pecoraro A; Virgilio A; Esposito V; Galeone A; Russo G; Russo A
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32290083
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
18. Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative.
Scuotto M; Rivieccio E; Varone A; Corda D; Bucci M; Vellecco V; Cirino G; Virgilio A; Esposito V; Galeone A; Borbone N; Varra M; Mayol L
Nucleic Acids Res; 2015 Sep; 43(16):7702-16. PubMed ID: 26250112
[TBL] [Abstract][Full Text] [Related]
19. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
20. Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells.
Civit L; Taghdisi SM; Jonczyk A; Haßel SK; Gröber C; Blank M; Stunden HJ; Beyer M; Schultze J; Latz E; Mayer G
Biochimie; 2018 Feb; 145():53-62. PubMed ID: 29054799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
